The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of
continuing pharmacy education (CPE). The 2023 ACCP Annual Meeting will provide up to 22.75 contact hours of CPE credit.
To receive CPE for Global Conference sessions, each attendee must claim the relevant CPE hours at www.accp.com/ce
within 60 days of the session. Statements of credit will be available at CPE Monitor within 2–3 business days.
To receive BCACP, BCCCP, BCGP, BCOP, or BCPS recertification credit for a recertification related program offered at the
2023 ACCP Annual Meeting, each attendee must purchase the recertification posttest and submit a passing score on the posttest
by the deadline listed in the session materials. The posttest will be made available on the "My Account" page of the ACCP website
on the published date in the session materials.
The Annual Meeting is designed for clinical practitioners, educators, residents, fellows,
and pharmacy students engaged in all aspects of clinical pharmacy.
The educational program developed for the 2023 Annual Meeting will provide attendees with new,
high-quality information that is both challenging and applicable to their practice. Program goals are to
- Update clinical pharmacists on new therapeutic advances and management strategies;
- Enhance attendees' clinical, research, teaching, and leadership skills;
- Discuss the challenges of expanding the scope of pharmacy practice and emerging practice models; and
- Present opportunities in clinical pharmacy and global health.
Antiplatelets, Anticoagulants, and Adverse Effects, Oh My! Antithrombotic Therapy Controversies in Clinical Practice
November 11, 2023 9:45 AM
Activity No. 0217-0000-23-107-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: Sarah Hanigan Lewis, Pharm.D., BCCP, BCPS
Learning Objectives
1. Differentiate patient characteristics and therapeutic areas that lead to uncertainties in the provision of antithrombotic therapy in clinical practice.
2. Evaluate available literature describing anticoagulation practices in special populations and controversial settings, such as obesity, hepatic disease, renal disease, and antiphospholipid syndrome.
3. Evaluate available literature describing current controversies in antiplatelet practices, such as duration and optimization of dual-antiplatelet therapy practices following intervention and combination therapy with anticoagulants.
4. Implement a process utilizing fibrinolytic therapy for acute ischemic stroke based on available information.
5. Formulate antiplatelet, anticoagulation, or fibrinolytic therapeutic regimens based on patient and disease state characteristics.
6. Design an antithrombotic therapy plan for special populations and/or controversial settings utilizing available literature and expert discussion.
Alteplase vs Tenecteplase for Stroke: Winner Take All?
- Speaker: Karen Berger, Pharm.D., BCPS
Anticoagulation Controversies in the Setting of Obesity and/or Liver Disease
- Speaker: James C. Coons, Pharm.D., FCCP, FACC, BCCP
Professor, Department of Pharmacy and Therapeutics and the Center for Clinical Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy and PGY2 Cardiology Pharmacy Residency Program Director at University of Pittsburgh Medical Center, Presbyterian Hospital, and Associate Fellowship Director for Clinical Pharmacogenomics
Optimization of Antiplatelet Regimens in the Ambulatory Care Setting
- Speaker: Craig J. Beavers, Pharm.D., FCCP, BCCP, BCPS
Navigating Kidney Disease, Hypercoagulable Disorders and Valve Replacement Anticoagulation in the Ambulatory Care Setting
- Speaker: Tiffany Vatterrodt, Pharm.D., BCACP
Case-Based Panelist Q&A and Discussion
"Can I Speak to a Representative?" Advocacy for the Profession
November 11, 2023 9:45 AM
Activity No. 0217-0000-23-109-L03-P; 1.50 contact hours.
Application Based Activity
- Moderator: William E. Dager, Pharm.D., FCCP, BCPS
Pharmacist Specialist, Department of Pharmaceutical Services,
University of California Davis Medical Center,
Sacramento, California
Learning Objectives
1. Define professional advocacy.
2. Assess strategies for advocating for policy and the profession.
3. Design effective messaging to support advocacy efforts.
4. Illustrate why professional advocacy is an important part of being a professional.
Use Your Advocacy or Lose Your Voice: Why You Should Care About Being Heard
- Speaker: John K. McGlew
Director, Government Affairs, American College of Clinical Pharmacy (ACCP), Washington, D.C.
Follow What Frustrates You: Finding Your Advocacy Voice, Women’s Health Example
- Speaker: Veronica Vernon, Pharm.D., BCACP, BCPS
Honing Your Message: Creating a Plan for Advocacy
- Speaker: Jenny Newlon, Pharm.D., Ph.D.
Q&A Panel
Conquering Your Fear of Biostatistics: A Chance to Practice
November 11, 2023 9:45 AM
Activity No. 0217-0000-23-111-L04-P; 1.50 contact hours.
Application Based Activity
- Moderator: Kyle J. Schmidt, Pharm.D., BCCCP
Associate Professor of Pharmacy Practice
Ferris State University, Big Rapids, MI
Learning Objectives
1. Describe common statistical concepts that are encountered in the biomedical literature.
2. Evaluate the appropriateness of the statistical methods from a published clinical trial.
3. Interpret the results and conclusions of a published clinical trial based on the statistical methods.
4. Discuss the factors and recommended methods for determining the clinical significance of a trial result.
5. Apply a systematic approach to incorporate the principles of biostatistics to commonly encountered pharmacy practice situations.
6. Illustrate how to apply statistics to solve real-world research questions.
Statistics Means Never Having to Say You’re Certain: A Brief Review of Major Biostatistical Concepts
- Speaker: Sharon K. Park, Pharm.D., M.Ed., BCPS
Professor & Assistant Dean for Academic Affairs and Continuous Quality Improvement
Notre Dame of Maryland University, Baltimore, MD
Pearls and Pitfalls for Interpreting the Biomedical Literature
- Speaker: Evan Williams, Pharm.D., MBA, BCACP, BCPS
Director of Accreditation and Associate Professor of Pharmacy
Roseman University of Health Sciences, Henderson, NV
Improving Your Statistical Confidence: Applying the Principles of Biostatistics to Pharmacy Practice & Research
- Speaker: Susan E. Smith, Pharm.D., BCCCP, FCCM
Clinical Associate Professor
University of Georgia College of Pharmacy
Athens, GA
Transitions of Care Through a New Lens: Advancement of Pharmacists’ and Technicians’ Roles in the Care Transition Spectrum
November 11, 2023 9:45 AM
Activity No. 0217-0000-23-117-L04-P; 1.50 contact hours.
Application Based Activity
- Moderator: Melissa Badowski, Pharm.D., MPH, FCCP, BCIDP, BCPS, AAHIVP
Clinical Associate Professor
University of Illinois at Chicago, College of Pharmacy
Chicago, Illinois
Learning Objectives
1. Outline potential challenges when incorporating pharmacists into the transitions of care process.
2. Construct framework for creating relationships with community pharmacies and pharmacists as a part of the transitions of care process.
3. Develop a plan for billing and reimbursement of pharmacist services for activities within the transitions of care process.
4. Evaluate the benefits and challenges of involving pharmacy technicians, student pharmacists, and post-graduate trainees in transitions of care process.
5. Formulate methods for pharmacists to create change at their institutions surrounding increased involvement in the transitions of care process.
6. Propose upcoming research initiatives and future directions for pharmacist involvement, activities, and reimbursement within transitions of care.
Transitions of Care: Opportunities at Hospital Discharge
- Speaker: Collin M. Clark, Pharm.D., BCGP, BCPS
Clinical Assistant Professor
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
Buffalo, New York
Transitions of Care: Opportunities in Ambulatory Care
- Speaker: Joel C. Marrs, Pharm.D., MPH, FCCP, FAHA, FASHP, FNLA, BCACP, BCCP, BCPS, CLS
Transitions of Care: Opportunities for Community Pharmacy
- Speaker: Jessica Wooster Thomas, Pharm.D., BCACP
Incorporating Inclusive Practices into Postgraduate Recruitment
November 11, 2023 9:45 AM
Activity No. 0217-0000-23-148-L04-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Frank North, Pharm.D., M.P.A.
President | Instructional Assistant Professor, National Pharmaceutical Association | Texas A&M University Rangel Pharmacy
- Speaker: Jacinda C. Abdul-Mutakabbir, Pharm.D., MPH, AAHIVP
Assistant Professor of Clinical Pharmacy at the University of California San Diego in the Skaggs School of Pharmacy and Pharmaceutical Sciences and the Division of the Black Diaspora and African American Studies
- Speaker: Tyler Marie Kiles, Pharm.D., BC-ADM
- Speaker: Sally Arif, Pharm.D., BCCP
Professor of Pharmacy Practice, Midwestern University College of Pharmacy-Downers Grove, IL
Cardiology Clinical Pharmacist, Rush University Medical Center, Chicago, IL.
Affiliated Faculty, Center for Community Health Equity, Chicago, IL.
Learning Objectives
1. Describe the current climate of diversity, equity, and inclusion in colleges of pharmacy and postgraduate training programs.
2. Identify actionable steps for diversifying the clinical pharmacy pipeline.
3. Describe the factors influencing black pharmacy students’ decision to pursue postgraduate training.
4. Identify strategies for postgraduate programs to enhance diversity, equity, and inclusion efforts in recruitment.
5. Identify the potential for bias within components of the residency recruitment process.
6. Describe changes made to the pharmacy residency recruitment process within a major academic medical center to minimize bias and increase DEI.
Module 1: Examining Outcomes, Standards, and Professional Competencies
November 11, 2023 1:30 PM
Activity No. 0217-0000-22-217-L04-P; 2.00 contact hours.
Knowledge Based Activity
- Moderator: Daniel S. Longyhore, Pharm.D., FCCP, BCACP
System Director for Knowledge Management, Geisinger, Enterprise Pharmacy
- Speaker: Pamela L. Stamm, Pharm.D., FCCP, BCACP, BCPS, CDE
Learning Objectives
1. Discuss different learning theories and constructs influence on teaching and learning at different levels.
2. Differentiate between traditional learning outcomes, ability-based outcomes, and competency-based education.
3. Review the different standards and professional competencies which guide pharmacy practice.
Central Nervous System PRN Focus Session — Caution! Baby on Board! Treatment Recommendations for Bipolar Disorders in Patients Who Are Pregnant
November 11, 2023 1:45 PM
Activity No. 0217-0000-23-127-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: Jason Chau, Pharm.D., BCACP, BCPS, MSCS
Learning Objectives
1. Compare and contrast the pharmacokinetic and pharmacodynamic changes that occur during pregnancy.
2. Analyze the efficacy, risks, and benefits of withholding or utilizing psychiatric medications for bipolar disorder during the prenatal and peripartum periods.
3. Evaluate current guideline recommendations and recent literature describing the use of psychiatric medications in pregnant patients living with a bipolar disorder.
4. Design an evidence-based treatment regimen for a pregnant patient living with a bipolar disorder, balancing risks and benefits for both mother and fetus.
5. Create an appropriate therapeutic monitoring plan across the continuum of pregnancy.
Medication Kinetic, Dynamic and Safety Challenges in Bipolar Disorders Treatment During Pregnancy
- Speaker: Ema Ferreira, Pharm.D., B.S.Pharm, MPH
Current Bipolar Disorders Treatment Recommendations in Patients who are Pregnant
- Speaker: Stephanie D. Nichols, Pharm.D., MPH, BCPP
Real-World Clinical Approaches and Considerations in the Treatment of Bipolar Disorders in Patients Who are Pregnant
- Speaker: Alicia B. Forinash, Pharm.D., FCCP, BCACP, BCPS
Professor of Pharmacy Practice
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy
St. Louis, Missouri
Women's Health PRN and Community-Based PRN Focus Session — Navigating the Dynamic Landscape of Pregnancy Termination in America
November 11, 2023 1:45 PM
Activity No. 0217-0000-23-147-L99-P; 1.50 contact hours.
Application Based Activity
- Moderator: Jaini Patel, Pharm.D., BCACP
Learning Objectives
1. Summarize the history and evolving landscape of abortion in America.
2. Differentiate clinical indications and modalities for pregnancy termination, including the role, therapeutics, and alternative uses of medications.
3. Discuss the barriers to clinical use and research for medications used for pregnancy termination.
4. Simulate real-world examples of implications of Roe v Wade reversal on medication abortion and patient care outcomes.
5. Propose the role of the pharmacists in providing comprehensive reproductive care while navigating the evolving landscape of abortion in America.
Foundation of Pregnancy Termination: Key Historical and Clinical Concepts
- Speaker: Lorinda Anderson, Pharm.D., BCPS
Overturning a New Leaf: Barriers and Real-World Implications on Medication Abortion in a Post-roe World
- Speaker: Veronica Vernon, Pharm.D., BCACP, BCPS
Evolution is Inevitable: Strategies for Pharmacists to Combat Clinical Paralysis in Providing Reproductive Care
- Speaker: Sarah Lynch, Pharm.D., BCACP
Clinical Assistant Professor, Director of Skills Education, Binghamton University, Binghamton, New York
Prerequisite Module: Research Primer
November 11, 2023 1:45 PM
Activity No. 0217-0000-22-221-L04-P; 4.00 contact hours.
Application Based Activity
- Speaker: Michael E. Ernst, Pharm.D., FCCP, BCGP
Clinical Professor, University of Iowa College of Pharmacy, Iowa City, Iowa - Speaker: Sandra L. Kane-Gill, Pharm.D., FCCP
Professor of Pharmacy and Therapeutics, University of Pittsburgh, School of Pharmacy, Pittsburgh, Pennsylvania - Speaker: Jacqueline McLaughlin, Ph.D.
Associate Professor, Educational Innovation and Research; Director of CIPhER, Center for Innovative Pharmacy Education and Research, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
- Speaker: Katy E. Trinkley, Pharm.D., Ph.D., FCCP, BCACP
Associate Professor, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy & Pharmaceutical Sciences, Aurora, Colorado
Learning Objectives
1. Describe the steps to formulating questions that are researchable.
2. Practice the interactive process of creating a defined and focused research question using PICO and FINER criteria.
3. Recognize basic concepts which underpin the research process and clinical investigation, such as the role of confounding variables and how different study designs account for their impact.
4. Describe key features of clinical research conducted using observational designs, survey research, educational research, and implementation science.
Leadership Primer, I
November 11, 2023 1:45 PM
Activity No. 0217-0000-22-225-L04-P; 4.00 contact hours.
Application Based Activity
- Speaker: Robert E. Smith, Pharm.D.
Professor Emeritus, Harrison School of Pharmacy, Auburn University, Auburn, Alabama - Speaker: Peter D. Hurd, Ph.D.
Professor and Department Chair, Pharmaceutical and Administrative Sciences, St. Louis College of Pharmacy, St. Louis, Missouri
Learning Objectives
1. Create meaning and reflection for your own leadership development path.
2. Discuss the importance of personal integrity and character in effective leadership.
3. Discuss the impact of too much or too little leadership and/or management on different types of organizations.
4. List the personal characteristics most people want in their leaders.
5. Describe the basics of organizational behavior.
6. Apply concepts and theories from organizational behavior literature to pharmacy settings.
7. Describe the various attributes of leadership.
8. Discuss the need for change in pharmacy practice environments.
9. Describe the various components of the Transtheoretical Model as it relates to leadership.
10. Apply the principles within the Transtheoretical Model to various practice settings.
11. Define leadership in terms used by various individuals.
12. Apply Blake and Mouton’s work on motivation to various practice settings.
EQUATOR Network Primer
November 11, 2023 1:45 PM
Activity No. 0217-0000-23-174-L04-P; 1.50 contact hours.
Knowledge Based Activity
- Speaker: Alan J. Zillich, Pharm.D., FCCP
William S. Bucke Professor and Head, Department of Pharmacy Practice, Purdue University College of Pharmacy, West Lafayette, Indiana
- Speaker: Erika J. Ernst, Pharm.D., FCCP, BCIDP
Associate Professor, Department of Pharmacy Practice and Science, University of Iowa College of Pharmacy; Clinical Pharmacy Specialist, infectious diseases, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Learning Objectives
1. Describe the mission and goals of the EQUATOR Network and the official journals of ACCP.
2. Access the writing and publishing resources available through the EQUATOR Network website.
3. Identify key reporting guidelines.
4. Select appropriate guidelines for a given research project.
5. Explain how guidelines such as CONSORT, STROBE, and PRISMA may be used in research and peer review activities.
Emergency Medicine PRN Focus Session — Status Traumaticus: Updates in Evidenced-Based Care in Trauma
November 11, 2023 1:45 PM
Activity No. 0217-0000-23-133-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Heather L. Blue, Pharm.D., BCPS
Learning Objectives
1. Describe the role of the emergency medicine pharmacist in trauma response.
2. Identify opportunities to optimize antibiotic regimens in the setting of open fracture prophylaxis.
3. Discuss how growing antibiotic resistance influences the antibiotic coverage for open fractures.
4. List the antibiotic prophylaxis recommendations for open skull fractures compared to long bone fractures.
5. Discuss the role of ED pharmacist involvement in viscoelastic testing in patients presenting with traumatic bleeding.
6. Recognize treatment options based on analysis of viscoelastic testing.
7. Review the most current guidelines for the use of viscoelastic testing in the treatment of trauma patients.
Manage the Damage: Open Fractures
- Speaker: Kirstin J. Kooda, Pharm.D., BCIDP, BCPS
Critical Care and Stewardship Pharmacist
Mayo Clinic
Rochester, MN
Stretch Your Knowledge: Optimizing Viscoelastic Testing in the Emergency Department
- Speaker: Brian W. Gilbert, Pharm.D., MBA, FCCM, FNCS, BCCCP
Pulmonary PRN Focus Session — As Good as GOLD: Updates in COPD Management
November 11, 2023 3:30 PM
Activity No. 0217-0000-23-146-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Melissa Lipari, Pharm.D., BCACP
Learning Objectives
1. Recognize risk factors for patients with COPD.
2. Classify de novo patients with COPD.
3. Select an appropriate pharmacologic regimen for chronic stable COPD.
4. Select an appropriate pharmacologic regimen for acute exacerbations of COPD.
5. Recognize strategies to improve patient access to COPD medications.
A Change Would Do You Good: COPD Risk Factor Management and Changes to Assessment of Severity
- Speaker: Dennis M. Williams, Pharm.D., FCCP, BCPS
Associate Professor,
University of North Carolina School of Pharmacy, Chapel Hill, North Carolina
Clinical Specialist, Pulmonary Medicine
UNC Medical Center
Using ABE to Guide COPD Therapy
- Speaker: Suzanne G. Bollmeier, Pharm.D., FCCP, BCPS, AE-C
Professor of Pharmacy Practice, St Louis College of Pharmacy;
Clinical Pharmacist, South County Health Center, St. Louis, Missouri
Show Me the Steroids! Updates in Acute COPD Exacerbation Management
- Speaker: Sheryl F. Vondracek, Pharm.D., FCCP, BCPS
Endocrine and Metabolism PRN Focus Session — Weighing the Options: Updates on the Management of Persons With Overweight or Obesity
November 11, 2023 3:30 PM
Activity No. 0217-0000-23-134-L01-P; 1.50 contact hours.
Knowledge Based Activity
Learning Objectives
1. Describe the clinical trial evidence supporting the use of newer medications for the management of overweight or obesity.
2. Identify the place in therapy for newer medications for the management of overweight or obesity that are not addressed by current guidelines.
3. Review the efficacy of medical devices and metabolic surgery relative to medications for the management of overweight or obesity.
4. Recognize characteristics that qualify patients for the management of overweight and obesity with surgical versus non-surgical options.
5. Summarize medication management considerations for persons with overweight or obesity that have undergone metabolic surgery.
How Low Can You Go? A Review of Newer Medications for the Management of Overweight or Obesity
- Speaker: Sara E. Lingow, Pharm.D., BCACP
Weighing the Options: A Review of Surgical Versus Non-surgical Options for the Management of Overweight and Obesity
- Speaker: Nicole Yvonne Nguyen, Pharm.D., BCPS
Digesting the Changes: A Review of Medication Management Considerations After Metabolic Surgery
- Speaker: Abby Lennon, Pharm.D., CDCES
Successful Billing and Contracting Strategies in Ambulatory Care
November 11, 2023 3:30 PM
Activity No. 0217-0000-23-149-L04-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Kaitlyn M. Bader, Pharm.D.
Medication Therapy Management (MTM) Pharmacist at M Health Fairview, Minneapolis, Minnesota
- Speaker: Ryan J. Wargo, Pharm.D., BCACP
- Speaker: James D. Hoehns, Pharm.D., FCCP, BCPS
- Speaker: Andrew N. Schmelz, Pharm.D., BCACP
Learning Objectives
1. Describe fee for service billing opportunities for clinical pharmacy services in ambulatory care settings.
2. Summarize value-based contracting strategies relevant to clinical pharmacists in team-based practice in ambulatory care settings.
3. Identify innovative funding models combining indirect and direct revenue sources to support clinical pharmacy services in ambulatory care.
4. Discuss chronic care management revenue sharing arrangements between a community pharmacy and primary care clinic.
Perioperative Care PRN Focus Session — Stop the Harm: Periprocedural and Trauma Antithrombotic Management Guideline Updates, Special Considerations, and Stewardship
November 11, 2023 3:30 PM
Activity No. 0217-0000-23-145-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Dustin Carneal, Pharm.D.
Learning Objectives
1. Describe venous thromboembolism prophylaxis burden and prophylaxis modalities in polytrauma patients.
2. Cite the literature and guidelines for anti-Xa guided dosing.
3. Select the preferred VTE prophylaxis strategy after major orthopedic surgery.
4. Review strategies for implementation of a pharmacist-led chemoprophylaxis protocol.
5. Discuss optimal pharmacotherapy for a patient who experienced acute traumatic hemorrhage.
6. Identify blood conservation strategies in various surgical populations.
Stop the Clot: Contemporary Pharmacologic Venous Thromboembolism Prophylaxis for the Trauma and Periprocedural Patient
- Speaker: Molly Droege, Pharm.D., BCPS
Stop the Clot: Updates in VTE Prophylaxis in Orthopedic Surgery and Implementation of Pharmacist-Led Services
- Speaker: Sara Jordan Hyland, Pharm.D., BCCCP
Stop the Bleed: Blood Conservation and Stewardship Strategies in the Acute Hemorrhage Surgical Patient
- Speaker: Kerilyn Petrucci, Pharm.D., BCCCP
Module 2: Aligning Goals and Objectives with Outcomes, Standards, and Professional Competencies
November 11, 2023 3:45 PM
Activity No. 0217-0000-22-218-L04-P; 2.00 contact hours.
Application Based Activity
- Moderator: Daniel S. Longyhore, Pharm.D., FCCP, BCACP
System Director for Knowledge Management, Geisinger, Enterprise Pharmacy
- Speaker: Angela L. Bingham, Pharm.D., FCCP, BCPS
Acting Chair and Clinical Associate Professor, Critical Care/Nutrition Support Clinical Pharmacy Specialist, PGY2 Critical Care Pharmacy Residency Program Director and Residency Programs Coordinator; Philadelphia College of Pharmacy, Saint Joseph's University; Philadelphia, PA
Learning Objectives
1. Compare and contrast knowledge, skills, and attitudes versus outcomes and competencies.
2. Discuss how to formulate goals and objectives to support outcome and competency development.
3. Create goals and objectives which align with outcomes, standards, and professional competencies.
New Investigator Award/Lecture — Rationally Optimized Antibiotic Combinations for Carbapenem-Resistant Klebsiella pneumoniae
November 12, 2023 8:25 AM
Activity No. 0217-0000-23-190-L01-P; 0.25 contact hours.
Knowledge Based Activity
- Award Winner: Zackery P. Bulman, Pharm.D.
Learning Objectives
1. Describe the limitations of current treatment options for serious infections caused by carbapenem-resistant Klebsiella pneumonia.
2. Discuss the benefits of identifying bacterial resistance genes to provide patient-specific therapy through molecular rapid diagnostics.
3. Identify alternative combination treatment strategies for carbapenem-resistant Klebsiella pneumoniae.
Therapeutic Frontiers Lecture — Expanding our Understanding and Stewardship of Drug Related Kidney Diseases
November 12, 2023 10:35 AM
Activity No. 0217-0000-23-195-L05-P; 0.50 contact hours.
Knowledge Based Activity
- Award Winner: Sandra L. Kane-Gill, Pharm.D., FCCP
Professor of Pharmacy and Therapeutics, University of Pittsburgh, School of Pharmacy, Pittsburgh, Pennsylvania
Learning Objectives
1. Review the contemporary definitions and classification framework for drug related kidney diseases.
2. Summarize the goals of nephrotoxin stewardship.
3. Explain hypervigilance and early detection of drug related kidney diseases as an approach to nephrotoxin stewardship.
Leadership Primer, II
November 12, 2023 1:45 PM
Activity No. 0217-0000-23-176-L04-P; 2.00 contact hours.
Application Based Activity
- Speaker: Robert E. Smith, Pharm.D.
Professor Emeritus, Harrison School of Pharmacy, Auburn University, Auburn, Alabama - Speaker: Peter D. Hurd, Ph.D.
Professor and Department Chair, Pharmaceutical and Administrative Sciences, St. Louis College of Pharmacy, St. Louis, Missouri
Learning Objectives
1. Describe the components of becoming a leader (Warren Bennis).
2. Apply concepts and theories from the leadership literature to pharmacy settings.
3. Describe the various attributes of leadership development.
4. Apply concepts and theories from organizational behavior literature to pharmacy settings.
5. Evaluate the use of principle-centered power in the pharmacy environment.
Ambulatory Care PRN Focus Session — Breaking Down Depression and Anxiety Management for the Ambulatory Care Pharmacist
November 12, 2023 2:15 PM
Activity No. 0217-0000-23-125-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: Jonathan C. Hughes, Pharm.D., BCACP
Learning Objectives
1. Apply evidence-based practices to the role of the ambulatory care pharmacist in the management of depression and anxiety.
2. Interpret the literature surrounding pharmacogenetics to guide depression and anxiety treatment.
3. Compare new drug therapies for the management of depression and anxiety.
4. Design a pharmacotherapy plan for patients with depression and anxiety including new drug therapies and practical implementation of pharmacogenetics.
5. Discuss strategies to navigate the challenges of depression and anxiety management in the primary care setting.
Ambulatory Care Pharmacist Management of Depression and Anxiety
- Speaker: Richard J. Silvia, Pharm.D., MA in Adult Education, FCCP, BCPP
Pharmacogenetics to Guide the Management of Depression and Anxiety
- Speaker: Jordan Baye, Pharm.D., MA, BCPS
Assistant Professor, South Dakota State University College of Pharmacy & Allied Health Professions
Feedback 360: Strategies for Giving and Responding to Feedback
November 12, 2023 2:15 PM
Activity No. 0217-0000-23-175-L04-P; 1.50 contact hours.
Knowledge Based Activity
- Speaker: Shannon W. Finks, Pharm.D., FCCP, BCCP, BCPS
Professor of Clinical Pharmacy and Translational Science, University of Tennessee College of Pharmacy
President, ZüpMedical Services, LLC, Memphis, Tennessee
- Speaker: Elias B. Chahine, Pharm.D., FCCP, FASCP, FFSHP, BCIDP
Professor of Pharmacy Practice, Palm Beach Atlantic University Gregory School of Pharmacy,
Clinical Pharmacy Specialist, Wellington Regional Medical Center
West Palm Beach, Florida
Learning Objectives
1. Recognize the importance of feedback in promoting professional development and growth in pharmacy residency and fellowship programs.
2. Identify effective communication strategies for giving and receiving feedback that promotes a culture of lifelong learning.
3. Recognize criteria-based feedback that is constructive and actionable.
4. Describe techniques for responding to feedback in a way to encourage reflection, self-awareness, and a growth mindset.
Comparing Apples and Oranges: What to Do When Guidelines Don’t Match
November 12, 2023 2:15 PM
Activity No. 0217-0000-23-110-L01-P; 4.00 contact hours.
Application Based Activity
Learning Objectives
1. Explain the process by which guidelines are developed.
2. Apply external guidelines within institutional practice settings.
3. Evaluate how evidence is incorporated into guideline relevance and grading.
4. Formulate individualized patient care plans utilizing recommendations from guidelines.
5. Differentiate between opposing guideline recommendations.
6. Illustrate the limitations of guidelines when developing a patient care plan.
7. Defend a stance on the weight of randomized controlled trials in guideline development.
8. Evaluate patient care management gaps within available guidelines.
9. Explore application of guidelines to various practice settings.
Opening Remarks
- Moderator: William E. Dager, Pharm.D., FCCP, BCPS
Pharmacist Specialist, Department of Pharmaceutical Services,
University of California Davis Medical Center,
Sacramento, California
Developing a Guideline and Grading the Evidence
- Speaker: Judith Jacobi, Pharm.D., FCCP, BCCCP
Critical Care Pharmacy Specialist, Methodist Hospital, Clarion Health, Indianapolis, Indiana
How Do I Adapt the Guidelines, Yet Individualize My Patient’s Care?
- Speaker: Ellen Jones, Pharm.D., BCACP
Associate Professor of Pharmacy Practice
Harding University College of Pharmacy
Searcy, Arkansas
Working with Guidelines and Developing a Policy
- Speaker: Richard J. Artymowicz, Pharm.D., FCCP, BCPS
Director of Pharmacy Services
Administrative Director of Sleep and Wound Care Services
Cape Regional Medical Center
Seaville, New Jersey
Panel Discussion/Question & Answer – Part One
Break
Opening Remarks
- Moderator: William E. Dager, Pharm.D., FCCP, BCPS
Pharmacist Specialist, Department of Pharmaceutical Services,
University of California Davis Medical Center,
Sacramento, California
Applying Conflicting Guidelines into Practice
- Speaker: Joseph J. Saseen, Pharm.D., FCCP, BCACP, BCPS
Debate: Guidelines Should Only Be Based on RCTs - Pro
- Speaker: Sarah A. Spinler, Pharm.D., FCCP
Professor, Department of Pharmacy Practice
Binghamton University School of Pharmacy and Pharmaceutical Sciences
Professor Emeritus
Philadelphia College of Pharmacy
Debate: Guidelines Should Be Based on RCT - Con
- Speaker: Aaron J. Roberts, Pharm.D., BCCP, BCPS
Senior Clinical Pharmacist, UC Davis Health, Pharmacy Department, Sacramento, California
Panel Discussion/Question & Answer – Part Two
Education and Training PRN Focus Session — We DID Start the Fire: Igniting Motivation in Pharmacy Learners
November 12, 2023 2:15 PM
Activity No. 0217-0000-23-132-L99-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Ashley N. Crowl-Glissman, Pharm.D., BCACP
Learning Objectives
1. Identify challenges for learner engagement in the classroom, experiential, and co-curricular settings.
2. Describe educational theories to motivate learning in diverse settings.
3. Discuss strategies to motivate and engage learners.
4. Outline an action plan to modify one learning experience (classroom, experiential, or co-curricular) to increase learner engagement.
5. Describe approaches and limitations for assessing learner engagement.
Motivating Learners in Didactic Settings
- Speaker: Jessica A. Starr, Pharm.D., FCCP, BCPS
Motivating Learners in Experiential Education
- Speaker: Mary K. Cozart, Pharm.D., BCACP, BCGP
Motivating Learners in Co-Curricular and Leadership Experiences
- Speaker: Rakhi Karwa, Pharm.D., BCPS
Pediatrics PRN Focus Session — Minimizing Antimicrobial Misuse: Stewardship Across the Pediatric Health System
November 12, 2023 2:15 PM
Activity No. 0217-0000-23-144-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Lucas Orth, Pharm.D., BCPPS
Learning Objectives
1. Describe current evidence for the involvement of respiratory bacteria in bronchiolitis and concurrent infections.
2. Discuss proposed strategies for use of diagnostic biomarkers to determination of respiratory infection etiology and selection of corresponding therapies.
3. Recognize opportunities for antimicrobial stewardship during transitions of care.
4. Review the appropriateness of empiric modification of antibiotic regimens prescribed for common pediatric infections in the ambulatory setting.
5. Identify differences between true IgE-mediated allergies and other antibiotic-related adverse drug reactions.
6. Outline potential approaches for implementation of allergy stewardship in a pediatric ambulatory setting.
7. Summarize strategies the pediatric pharmacy practitioner can implement to reduce unnecessary antimicrobial resistance in children.
Stewardship Starts Young: Curbing Antimicrobial Misuse in the Management of Bronchiolitis and Concurrent Infections
- Speaker: Kailynn DeRonde, Pharm.D., BCIDP
Changing the Course: Reducing Antimicrobial Exposure in Transitions of Care and Ambulatory Care Clinics
- Speaker: Wiyanna K. K. Bruck, Pharm.D., BCIDP, BCPPS, BCPS
Low Risk and High Reward: Outpatient Allergy Delabeling Opportunities
- Speaker: Christine E. MacBrayne, Pharm.D., MSCS, BCIDP
Geriatrics PRN Focus Session — Aching While Aging: Comprehensive and Novel Approaches to Chronic Pain Management in Older Adults
November 12, 2023 4:00 PM
Activity No. 0217-0000-23-135-L08-P; 1.50 contact hours.
Application Based Activity
- Moderator: Elsen C. Jacob, Pharm.D., MS, BCGP, BCPS, CPPS
Assistant Professor, St. John’s University College of Pharmacy & Health Sciences;
Clinical Pharmacy Faculty, Mount Sinai Hospital
New York, New York
Learning Objectives
1. Summarize how changes associated with aging impacts the appropriate management of chronic pain in older adults.
2. Apply best practices for chronic pain management, including opioid and non-opioid therapies, and risk mitigation in older adults.
3. Examine the evidence supporting the use of unapproved therapies, including cannabis and ketamine, in the treatment of chronic pain in older adults.
4. Recommend the appropriate use of unapproved therapies, including cannabis and ketamine, for chronic pain management in older adults.
5. Explore the impact of social determinants of health on chronic pain treatment.
6. Recommend psychosocial and ancillary resources for older adults with chronic pain.
7. Develop a holistic pain management regimen in the older adult.
Pharmacotherapeutic Approach to Chronic Pain Management in Older Adults
- Speaker: Lori A. Reisner, Pharm.D.
University of California - San Francisco, San Francisco, California
Recent Trends in Unapproved, Non-Opioid Treatment of Chronic Pain in Older Adults
- Speaker: Danielle Fixen, Pharm.D., BCGP
Incorporating Social Services for a Holistic Approach to Pain Management in the Older Adult
- Speaker: Julianna M. Fernandez, Pharm.D., BCGP, BCPS
Cardiology PRN Focus Session — Getting Over the Bump: Managing Cardio-Obstetric Complications
November 12, 2023 4:00 PM
Activity No. 0217-0000-23-126-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: Kate Cabral, Pharm.D., FACC, BCCP
Learning Objectives
1. Evaluate for associated risk factors of common CVD states in peripartum/postpartum patients.
2. Create a therapeutic plan based on evidence-based treatment options incorporating peripartum and postpartum considerations.
3. Determine considerations on safe contraception planning for women as it pertains to specific CV disease state.
4. Describe the pharmacists’ role in managing CVD in the peripartum/postpartum population.
Treatment of Hypertension Peripartum and Postpartum
- Speaker: Nicholas W. Carris, Pharm.D., BCPS
Treatment of Heart Failure/Cardiomyopathies During and After Pregnancy
- Speaker: Lindsey Federle, Pharm.D., BCCP, BCPS
Treatment of Arrhythmias, Including Stroke Prevention in Atrial Fibrillation, During and After Pregnancy
- Speaker: Dimpa D. Choksi, Pharm.D., BCCP, BCPS
The Treatment of Thromboembolism During/After Pregnancy
- Speaker: Matthew P. Lillyblad, Pharm.D., BCCCP, BCCP
Q&A Panel
Drug Information PRN Focus Session — The Intersection of Formulary Management, Technology, and Pharmacogenomics to Maximize Patient Care
November 12, 2023 4:00 PM
Activity No. 0217-0000-23-131-L05-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Miki A. Goldwire, Pharm.D., MS, MA, BCPS
Learning Objectives
1. Identify the components of an effective drug formulary process, including the evaluation of safety and efficacy, logistical and practical considerations, and the use of pharmacogenomics and precision medicine.
2. Describe the role of technology in formulary management, e.g., maximizing the electronic health record, smart infusion drug library, automated dispensing cabinet software.
3. Explain the importance of integrating technology updates into the formulary process to ensure safe medication use and access to appropriate therapy for patients.
4. Discuss risks associated with poorly implemented formulary changes and proactive measures to prevent errors and ensure appropriate patient therapy.
5. Analyze the impact of pharmacogenomics on formulary management, including the challenges and opportunities that arise from precision medicine approaches to prescribing.
6. Evaluate the current and future impact of pharmacogenomics on the formulary process and strategies for integrating precision medicine into formulary management paradigms.
Utilizing Technology for Safe Implementation of Formulary Changes: A Behind the Scenes Look
- Speaker: Derek L. Grimm, Pharm.D., BCPS
Current and Future Impact of Pharmacogenomics on Formulary Management
- Speaker: Larisa H. Cavallari, Pharm.D., FCCP
Professor; Co-Director, Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, Florida
BCOP Clinical Session — Emerging Therapies and Clinical Controversies in the Management of Diffuse Large B-Cell Lymphoma
November 12, 2023 4:00 PM
Activity No. 0217-9999-23-075-L01-P; 2.00 contact hours.
Application Based Activity
- Speaker: Donald C. Moore, III, Pharm.D., FCCP, BCPS
- Speaker: Shawn P. Griffin, Pharm.D., BCOP
- Speaker: Katie S. Gatwood, Pharm.D., BCOP
Stem Cell Transplant and Cellular Therapy Clinical Pharmacist Specialist, Vanderbilt University
Learning Objectives
1. Assess clinical data evaluating the integration of new therapies into the first-line treatment of diffuse large B-cell lymphoma (DLBCL).
2. Compare central nervous system prophylaxis strategies for high-risk patients with DLBCL.
3. Identify considerations for sequencing new therapeutic modalities for relapsed/refractory DLBCL.
4. Apply recently published literature evaluating the role of chimeric antigen receptor T-cell therapies in DLBCL.
5. Recommend supportive care measures for managing unique toxicities associated with newer therapies for DLBCL.
BCOP Clinical Session — Amyloidosis: Updates and Clinical Management
November 13, 2023 8:00 AM
Activity No. 0217-9999-23-076-L01-P; 2.00 contact hours.
Application Based Activity
- Speaker: Mitchell Edward Hughes, Pharm.D., BCOP
- Speaker: Oxana Megherea, Pharm.D., BCOP
- Speaker: Breanna J. Taylor, Pharm.D., BCOP
Learning Objectives
1. Develop appropriate counseling points on therapy recommendations for amyloidosis.
2. Identify initiation of therapy for light-chain (AL) amyloidosis patients as either first-line or relapsed/refractory disease.
3. Compose a treatment plan for a patient with transthyretin-related (ATTR) amyloidosis based on recommendations from current guideline recommendations.
4. Interpret the financial impact of therapy of disease modifying agents and supportive care therapies in amyloidosis.
5. Prepare best supportive care recommendations and monitoring for patients with amyloidosis.
BCACP/BCGP Clinical Session — Filtering Out the Old, and Reabsorbing the New: Updates in the Management of Chronic Kidney Disease
November 13, 2023 8:15 AM
Activity No. 0217-9999-23-078-L01-P; 1.00 contact hour.
Application Based Activity
- Speaker: Lalita Prasad-Reddy, Pharm.D., MS, FCCP, BCACP, BCPS, CDE
Learning Objectives
1. Identify the dangers of race-based correction when applied to kidney function estimation.
2. Given a patient case, compare and contrast strategies to reduce kidney disease progression.
3. Given a patient case, design a management plan for managing CKD progression and complications.
Getting Things Done in Organizations
November 13, 2023 8:30 AM
Activity No. 0217-0000-21-238-L04-P; 2.00 contact hours.
Application Based Activity
- Speaker: Robert E. Smith, Pharm.D.
Professor Emeritus, Harrison School of Pharmacy, Auburn University, Auburn, Alabama
Learning Objectives
1. Review personal development principles.
2. Discuss the elements of successful teams.
3. Relate the importance of controlling ego.
4. Apply the learned concepts to roles within ACCP and back home.
5. Conduct a warm-up team building exercise.
The Role of Tenecteplase vs. Alteplase, Neurological Focus
November 13, 2023 8:30 AM
Activity No. 0217-0000-23-097-L01-P; 1.50 contact hours.
Application Based Activity
- Speaker: Sheshadri Hoque, Pharm.D.
Critical Care Clinical Pharmacy Specialist, Inova Alexandria Hospital
Alexandria, VA
- Speaker: Lina Saliba, Pharm.D., BCCCP, BCPS
Critical Care Clinical Pharmacy Specialist, Inova Fairfax Medical Campus
Falls Church, VA
Learning Objectives
1. Describe the pathophysiology of acute ischemic stroke (AIS).
2. Differentiate AIS patients who are candidates for thrombolytic therapy.
3. Evaluate the current literature regarding use of tenecteplase in AIS.
4. Compare and contrast key pharmacokinetic, administration, and dosing parameters for tenecteplase and alteplase in AIS.
5. Analyze the role of tenecteplase in other indications, such as myocardial infarction and pulmonary embolism.
It's Bean Too Long: A New Standard of Care for Chronic Kidney Disease
November 13, 2023 9:00 AM
Activity No. 0217-0000-23-112-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: Sarah Hanigan Lewis, Pharm.D., BCCP, BCPS
Learning Objectives
1. Discuss the pathophysiology of chronic kidney disease (CKD) and its associated comorbidities.
2. Evaluate common laboratory parameters to identify and stage CKD.
3. Discuss the current evidence‐based recommendations for managing CKD comorbidities to reduce cardiovascular risk.
4. Evaluate the literature supporting the use of emerging therapies in the management of patients with CKD.
5. Discuss the role of SGLT‐2 inhibitors and finerenone in the management of patients with CKD.
6. Design a therapeutic care plan for a patient with CKD that incorporates patient selection, education and follow‐up for new drug therapies.
Can’t Keep Doing the Same Old Things and Expecting Different Results: Addressing the Burdens and Unmet Needs for Patients With Chronic Kidney Disease (CKD)
- Speaker: Wendy L. St. Peter, Pharm.D., FCCP
Professor
University of Minnesota – College of Pharmacy
Minneapolis, Minnesota
Urine the Spotlight Now! A Resurgence in Drug Development and Therapies for CKD
- Speaker: Joshua J. Neumiller, Pharm.D., CDE
Getting Into the Flow: Incorporating New Therapies Into Your Clinical Practice
- Speaker: Tracy Anderson-Haag, Pharm.D., BCTXP
Just in Time: Late Breaking Clinical Trials
November 13, 2023 9:00 AM
Activity No. 0217-0000-23-113-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Kyle J. Schmidt, Pharm.D., BCCCP
Associate Professor of Pharmacy Practice
Ferris State University, Big Rapids, MI
Learning Objectives
1. List recently published trials that have the potential to alter practice in infectious diseases, cardiology, critical care, and internal medicine.
2. Summarize recent literature findings with the potential to impact the practice of infectious diseases care pharmacy.
3. Summarize recent literature findings with the potential to impact the practice of cardiology pharmacy.
4. Summarize recent literature findings with the potential to impact the practice of critical care pharmacy.
5. Summarize recent literature findings with the potential to impact the practice of internal medicine pharmacy.
6. Describe ongoing and/or future investigations that have the potential to alter pharmacy practice in critical care, cardiology, internal medicine, and/or infectious diseases.
Late Breaking Clinical Trials: Infectious Diseases
- Speaker: Jerod Nagel, Pharm.D., BCIDP
Late Breaking Clinical Trials: Ambulatory Care
- Speaker: Erika L. Hellenbart, Pharm.D., BCPS
Late Breaking Clinical Trials: Critical Care
- Speaker: Kaitlin M. Alexander, Pharm.D.
Late Breaking Clinical Trials: Acute Care
- Speaker: Trina Huynh, Pharm.D., BCPS
Panelist Discussion and Interaction
Personalizing Therapy Across Medical Specialties: Application of Pharmacogenomics and Pharmacokinetics to Optimize Treatment Benefit and Minimize Risks
November 13, 2023 9:00 AM
Activity No. 0217-0000-23-115-L04-P; 1.50 contact hours.
Application Based Activity
- Moderator: Christine M. Walko, Pharm.D., FCCP, BCOP
Learning Objectives
1. Select primary literature and clinical guidelines to inform practice recommendations and medical therapy management decisions.
2. Translate large-panel germline pharmacogenomic results into pharmacotherapeutic recommendations.
3. Apply evidence-based medicine to pharmacogenomic and pharmacokinetic-guided therapy in a case-based patient scenario.
4. Formulate treatment recommendations based on microbial pharmacokinetic results.
5. Construct treatment recommendations based on levels of evidence and tumor genomic test results.
Integrating Large Panel Pharmacogenomic Testing Into Comprehensive Medication Management
- Speaker: Kelly E. Caudle, Pharm.D., Ph.D., FCCP
Clinical Pharmacogenetics Implementation Consortium (CPIC) Co-PI and Director
St. Jude Children’s Research Hospital
Memphis, Tennessee
Using Pharmacokinetics to Optimize Antimicrobial Therapy Management
- Speaker: Veena Venugopalan, Pharm.D., BCIDP
Translating Cancer Genomic Results Into Treatment Recommendations
- Speaker: James Kevin Hicks, Pharm.D., Ph.D., FCCP
International Consensus Recommendations for the use of Prolonged Infusion β-lactams
November 13, 2023 9:00 AM
Activity No. 0217-0000-23-177-L01-P; 1.00 contact hour.
Knowledge Based Activity
- Speaker: Lisa Hong, Pharm.D., BCPS
Associate Professor and Director of Interprofessional Education, Loma Linda University School of Pharmacy
- Speaker: Marc H. Scheetz, Pharm.D., FCCP
Associate Dean of Research, Professor, and Director of Pharmacometrics Center of Excellence
Midwestern University Chicago College of Pharmacy
Downers Grove, Illinois
Learning Objectives
1. Summarize the evidence supporting efficacy of prolonged- versus short-infusion beta-lactam antibiotics.
2. Explain the safety profiles of prolonged- versus short-infusion beta-lactam antibiotics.
3. Explain the strength of evidence for use of prolonged-infusion beta-lactam antibiotics in various sub-populations of patients.
BCACP/BCGP Clinical Session — The Cholesterol Limbo: How Low Should You Go?
November 13, 2023 9:30 AM
Activity No. 0204-9999-23-290-L01-P; 1.50 contact hours.
Application Based Activity
- Speaker: Joel C. Marrs, Pharm.D., MPH, FCCP, FAHA, FASHP, FNLA, BCACP, BCCP, BCPS, CLS
- Speaker: Matthew Kostoff, Pharm.D., BCACP, BCPS
Learning Objectives
1. Summarize treatment recommendations included in the 2018 ACC-AHA, 2019 ESC/EAS, and 2020 AACE/ACE hypercholesterolemia guidelines, as well as the ACC Expert Consensus Decision Pathway on the role of nonstatin therapies.
2. Apply guidelines for the management of adult and older adult patients with hypercholesterolemia.
3. Evaluate challenges with the application of the updated guidelines and recent clinical trials when treating hypercholesterolemia in special populations, including older adults.
Role of Volatile Anesthetics in Critically Ill Patients, Perioperative Focus
November 13, 2023 10:15 AM
Activity No. 0217-0000-23-096-L01-P; 1.50 contact hours.
Application Based Activity
- Speaker: Sarah Blackwell, Pharm.D., BCCCP, BCPS
Clinical Pharmacy Specialist, Medical Critical Care
PGY1 Pharmacy Residency Director
Princeton Baptist Medical Center
Birmingham, AL
Learning Objectives
1. Analyze the proposed mechanisms through which sevoflurane, isoflurane, desflurane, halothane, and nitrous oxide induce general anesthesia.
2. Describe the partition coefficients and other properties which influence the delivery of volatile anesthetics to patients being anesthetized.
3. Examine the devices which allow for the delivery of volatile anesthetics in the intensive care unit setting.
4. Compare and contrast the risks and benefits of volatile anesthetics with those of intravenous sedatives in critically ill patients.
BCACP/BCGP Clinical Session — Weighing In: The Risks and Benefits of Treating Obesity in Adults and Older Adults
November 13, 2023 11:15 AM
Activity No. 0204-9999-23-327-L01-P; 1.50 contact hours.
Application Based Activity
- Speaker: Lourdes Cross, Pharm.D., BCACP, CDE
- Speaker: Dana G. Carroll, Pharm.D., BCGP
Learning Objectives
1. Summarize evidence-based recommendations for weight loss management.
2. Evaluate recent literature addressing the use of newer anti-obesity medications in adults and older adults.
3. Compare the safety and efficacy of anti-obesity medications in adults and older adults.
4. Recommend a treatment and monitoring plan for weight management using patient-specific factors.
Anticoagulant Monitoring for Patients in the Critically Ill Setting & Perioperative Management of the Bleeding Patient
November 13, 2023 1:00 PM
Activity No. 0217-0000-23-098-L01-P; 3.00 contact hours.
Application Based Activity
- Speaker: Gianna Lauren H. Casal, Pharm.D., BCCCP
Clinical Pharmacist—Surgical/Trauma/Burn Critical Care, Massachusetts General Hospital
Per Diem Clinical Pharmacist, Yale New Haven Hospital
- Speaker: Corey J. Witenko, Pharm.D., FCCM, BCCCP, BCPS
Medical Science / Clinical Trial Liaison, Theravance Biopharma
New York, New York
Learning Objectives
1. Analyze standard anticoagulation monitoring to identify patients that may warrant alternative assessments.
2. Distinguish between discordant laboratory markers to ensure appropriate anticoagulant monitoring.
3. Propose an individualized anticoagulation monitoring plan based on interacting disease states.
4. Identify barriers to implementing alternative anticoagulant assays.
5. Assess pharmacotherapeutic management strategies to prevent and treat bleeding in perioperative patients with a history of antithrombotic use or an inherited bleeding disorder.
6. Interpret viscoelastic testing to formulate a treatment plan for a bleeding patient.
7. Appraise the current literature surrounding blood factor stewardship and its impact on patient outcomes and the pharmacy department.
Balancing the Scales: Accounting for Well-being, Resilience, and Growth Mindset in Students and Residents
November 13, 2023 1:15 PM
Activity No. 0217-0000-23-102-L04-P; 2.00 contact hours.
Knowledge Based Activity
- Moderator: Daniel S. Longyhore, Pharm.D., FCCP, BCACP
System Director for Knowledge Management, Geisinger, Enterprise Pharmacy
- Speaker: Kylie N. Barnes, Pharm.D., FCCP, BCPS
Director of Applied Skills and OSCE Implementation University of Missouri Kansas City School of Pharmacy
- Speaker: Elias B. Chahine, Pharm.D., FCCP, FASCP, FFSHP, BCIDP
Professor of Pharmacy Practice, Palm Beach Atlantic University Gregory School of Pharmacy,
Clinical Pharmacy Specialist, Wellington Regional Medical Center
West Palm Beach, Florida
Learning Objectives
1. Differentiate the meaning of terms linked to well-being and burnout.
2. Describe cases of balance, stress, and burnout in order to identify key signs and symptoms of concern.
3. Review the reliability and applicability of different approaches to measuring and monitoring stress and burnout potential.
4. Define the characteristics of resilience and a growth mindset.
5. Review approaches to developing resilience and a growth mindset in learners and practitioners.
6. Describe the relationship between stress, burnout, resilience, and a growth mindset.
Nephrology PRN Focus Session — Controversies in Diuretic Use in Chronic Kidney Disease
November 13, 2023 1:45 PM
Activity No. 0217-0000-23-143-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Lavinia Salama, Pharm.D., BCACP, BC-ADM, CDE
Learning Objectives
1. Identify diuretics classes and common indications for their use in patients with chronic kidney disease.
2. Explain the pharmacokinetic and pharmacodynamic properties that are likely to impact diuretic use in patients with chronic kidney disease.
3. Summarize scientific literature regarding the safety and efficacy of using diuretics in chronic kidney disease.
4. Recognize emerging literature regarding the use of diuretics in chronic kidney disease.
5. Select an appropriate diuretic for patients with chronic kidney disease based on the specific diuretics’ mechanism of action, adverse effects, and monitoring parameters.
6. Create a patient care plan for diuretic initiation, monitoring, and follow-up for individuals with decreased kidney function.
Review of Diuretics Classes Including Pharmacokinetic (PK) and Pharmacodynamic (PD) in Patients with CKD
- Speaker: Mary Vilay, Pharm.D.
Associate Professor, University of New Mexico College of Pharmacy, Albuquerque, New Mexico
Thiazide Diuretics in Chronic Kidney Disease: "To Use or Not to Use?"
- Speaker: Rebecca A. Maxson, Pharm.D., BCPS
PSAP Live: Updates in Endocrinology
November 13, 2023 1:45 PM
Activity No. 0217-0000-23-201-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: Cynthia A. Sanoski, Pharm.D., FCCP, BCPS
Department Chair, Associate Professor of Pharmacy Practice, Thomas Jefferson University, Philadelphia, Pennsylvania. - Speaker: Lalita Prasad-Reddy, Pharm.D., MS, FCCP, BCACP, BCPS, CDE
- Speaker: Diana Isaacs, Pharm.D., FCCP, BCACP, BCPS
Endocrine Clinical Pharmacy Specialist, CGM and Remote Monitoring Program Coordinator, Cleveland Clinic Endocrinology & Metabolism Institute, Cleveland, Ohio
- Speaker: Haley N. Johnson, Pharm.D., BCPS
Learning Objectives
1. Based upon guideline recommendations, develop a patient-centered treatment plan, including pharmacotherapy selection and use of continuous glucose monitoring (CGM).
2. Develop strategies to overcome patient barriers to guideline-recommended technology and therapies.
3. Develop a pharmacologic treatment plan for a hospitalized patient with diabetes.
4. Evaluate candidacy for use of diabetes technology in the inpatient setting on an institution and patient-specific basis.
5. Taking into account patient-specific factors, design a therapeutic plan to reduce the risk of microvascular and macrovascular complications of diabetes.
6. For a given patient, evaluate structural vulnerabilities that may affect patient outcomes.
Personal Leadership Development
November 13, 2023 1:45 PM
Activity No. 0217-0000-22-226-L04-P; 4.00 contact hours.
Application Based Activity
- Speaker: Robert E. Smith, Pharm.D.
Professor Emeritus, Harrison School of Pharmacy, Auburn University, Auburn, Alabama - Speaker: Peter D. Hurd, Ph.D.
Professor and Department Chair, Pharmaceutical and Administrative Sciences, St. Louis College of Pharmacy, St. Louis, Missouri
Learning Objectives
1. Create definitions for leadership and management.
2. Discuss the importance of obedience to principles as a primary means for leading a successful life.
3. Express how you can assume responsibility for achieving a full and balanced professional life.
4. Construct a personal mission statement you can use as a guide to personal and professional achievement.
5. Describe the importance of taking personal responsibility for self-leadership in developing leadership capabilities.
6. Describe ways that you can be proactive when working with others in various settings, such as performance evaluation.
7. Apply time management strategies, based on your mission statements, to your personal and professional leadership challenges.
Module 1: Research Basics
November 13, 2023 1:45 PM
Activity No. 0217-0000-22-222-L04-P; 4.00 contact hours.
Application Based Activity
- Speaker: Gary L. Cochran, Pharm.D.
Associate Professor of Pharmacy Practice, University of Nebraska Medical Center, College of Pharmacy, Omaha, Nebraska - Speaker: Sandra L. Kane-Gill, Pharm.D., FCCP
Professor of Pharmacy and Therapeutics, University of Pittsburgh, School of Pharmacy, Pittsburgh, Pennsylvania - Speaker: Jacqueline McLaughlin, Ph.D.
Associate Professor, Educational Innovation and Research; Director of CIPhER, Center for Innovative Pharmacy Education and Research, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
- Speaker: Katy E. Trinkley, Pharm.D., Ph.D., FCCP, BCACP
Associate Professor, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy & Pharmaceutical Sciences, Aurora, Colorado
Learning Objectives
1. Describe common study designs used in observational, educational, health-services and cross-sectional/survey projects.
2. Discuss the advantages and disadvantages of the various study designs.
3. Discuss the optimal approach and suggested study design for your defined research question.
4. Identify resources needed for your research question and ideas for securing support.
GI/Liver/Nutrition PRN and Pain and Palliative Care PRN Focus Session — Nutrition Support and Symptom Considerations for Palliative Care, Hospice, and End of Life
November 13, 2023 1:45 PM
Activity No. 0217-0000-23-136-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: Thomas B. Gregory, Pharm.D., BCPS
Learning Objectives
1. Examine artificial enteral and parenteral nutrition and hydration use in palliative care, hospice, and end of life.
2. Analyze clinical outcomes related to nutrition and hydration deficits in palliative care, hospice, and end of life patient populations.
3. Interpret professional society ethical guidelines for clinicians on artificially administered nutrition and hydration.
4. Analyze routine pharmacologic and non-pharmacologic symptom management strategies during the active dying phase.
5. Recommend pharmacotherapeutic interventions for refractory or intractable symptoms at end of life.
Nutrition Support for Palliative Care, Hospice, and End of Life
- Speaker: Sarah Cogle, Pharm.D., BCCCP, BCNSP
Symptom Considerations for Palliative Care, Hospice, and End of Life
- Speaker: Michelle D. Huber, Pharm.D., BCGP
BCACP Clinical Session — Changing the Way Patients Access Reproductive Healthcare
November 13, 2023 2:00 PM
Activity No. 0217-9999-23-077-L01-P; 2.00 contact hours.
Application Based Activity
- Speaker: Cynthia A. King, Pharm.D., BCACP
- Speaker: Lorinda Anderson, Pharm.D., BCPS
- Speaker: Jordan Cloonan, Pharm.D.
Learning Objectives
1. Assess barriers to access of hormonal contraceptives.
2. Examine advocacy efforts to expand pharmacist's role to prescribe hormonal contraceptives.
3. Compare and contrast key pharmacology differences between oral contraceptive types including new drug updates.
4. Apply tools and technology to determine patient eligibility for pharmacist prescribed hormonal contraceptives.
Hematology/Oncology PRN and Pharmacokinetics/Pharmacodynamics/Pharmacogenomics PRN Focus Session — Pharmacogenomics in Oncology Practice: Unraveling the Science of Pharmacogenomics for Implementation in Cancer Treatment and Supportive Care
November 13, 2023 3:30 PM
Activity No. 0217-0000-23-139-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Farah Raheem, Pharm.D., BCOP
Clinical Oncology Pharmacist
Mayo Clinic, Phoenix, AZ
Learning Objectives
1. Outline evidence-based guidance for genes associated with medications used in cancer treatment and supportive care.
2. Interpret pharmacogenomic test results to guide medications use in cancer treatment and supportive care.
3. Describe role of pharmacist in incorporating pharmacogenomics into practice.
4. Identify resources and processes for implementing pharmacogenomics into oncology practice.
5. Discuss challenges and limitations of incorporating pharmacogenomic testing into practice.
Clinical Application of Pharmacogenomics in Cancer Treatment and Supportive Care
- Speaker: Cyrine E. Haidar, Pharm.D., BCOP, BCPS
St. Jude Children’s Hospital, Memphis, Tennessee
Key Pharmacogenomic Implementation Considerations in Oncology Practice
- Speaker: Jai N. Patel, Pharm.D.
Critical Care PRN Focus Session — Chill Out: Targeted Temperature Management Updates and Controversies in the ICU
November 13, 2023 3:30 PM
Activity No. 0217-0000-23-130-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Susan E. Smith, Pharm.D., BCCCP, FCCM
Clinical Associate Professor
University of Georgia College of Pharmacy
Athens, GA
Learning Objectives
1. List indications for targeted temperature management.
2. Review evidence on the clinical outcomes of therapeutic hypothermia as compared to normothermia in patients with cardiac arrest, including evidence in patients of different racial/ethnic backgrounds.
3. Summarize physiologic changes that occur during the phases of targeted temperature management.
4. Discuss the impact of pharmacokinetic changes on commonly used medications in the intensive care unit and dosing considerations in targeted temperature management.
5. Recognize the role of the critical care pharmacist on the interprofessional team to promote safe and effective medication delivery to patients undergoing targeted temperature management.
Skating on Thin Ice: Recent Evidence-Based Updates in Targeted Temperature Management
- Speaker: Jolie Gallagher, Pharm.D., BCCCP
The Cold Truth: Pharmacokinetic Changes During Targeted Temperature Management and Implications for Drug Dosing
- Speaker: Kaitlin Landolf, Pharm.D., BCCCP
Just the Tip of the Iceberg: Updates and Controversies for Analgesia and Sedation in TTM Patients
- Speaker: Katherine M. Spezzano, Pharm.D., MBA, BCCCP
Infectious Diseases PRN Focus Session — Challenging the Dogma: Updates in Controversial Infectious Diseases Practices
November 13, 2023 3:30 PM
Activity No. 0217-0000-23-142-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: David W. Kubiak, Pharm.D., BCIDP, BCPS
Learning Objectives
1. Define pharmacokinetic and pharmacodynamic principles of intravenous and oral antibiotics necessary for target attainment in deep-seated infections.
2. Discuss data-driven approaches for the transition to oral and long-acting intravenous antibiotics for deep-seated infections.
3. Describe the challenges with urinary tract infection (UTI) management in the geriatric population and/or those with altered mental status.
4. Discuss various UTI treatment strategies and recommendations for this patient population.
5. Describe the nuances of initial treatment selection of oral vancomycin versus fidaxomicin for the treatment of Clostridioides difficile infection (CDI).
6. Discuss patient-specific factors for agent selection for prevention and treatment of recurrent CDI.
No Strings Attached: Early Transition to Oral Antibiotics or Long-Acting Lipoglycopeptides for Deep-Seated Infections
- Speaker: Esther Y. Golnabi, Pharm.D., BCIDP
To Treat or Not to Treat: Management of UTIs in Geriatric Patients and Patients With Altered Mental Status
- Speaker: Spencer H. Durham, Pharm.D., FCCP, BCIDP, BCPS
Assistant Clinical Professor, Pharmacy Practice, Auburn University
Harrison College of Pharmacy, Auburn, Alabama
Don’t Call It a Comeback: Updates in the Management of Recurrent Clostridioides Difficile Infection
- Speaker: Natasha Pettit, Pharm.D., BCIDP
BCGP Clinical Session — You're Losing It: Better Strategies for Addressing Unintentional Weight Loss in the Older Adult
November 13, 2023 4:15 PM
Activity No. 0204-9999-23-295-L01-P; 1.00 contact hour.
Application Based Activity
- Speaker: Amie Taggart Blaszczyk, Pharm.D., BCGP, BCPS
Professor and Division Head – Geriatrics
Texas Tech University HSC School of Pharmacy
Dallas, Texas
Learning Objectives
1. Describe the epidemiology, prevalence, and regulatory consequences of problematic weight loss in the older adult.
2. Identify contributors to problematic weight loss in the older adult population.
3. Critically evaluate the literature supporting or refuting the use of non-pharmacological and pharmacological strategies in weight loss in the older adult.
4. Develop patient-specific strategies for addressing problematic weight loss.
Pain Management in Persons with a Substance Related Disorder (SRD)
November 14, 2023 8:30 AM
Activity No. 0217-0000-23-120-L01-P; 1.50 contact hours.
Application Based Activity
- Speaker: Rebecca Hoss, Pharm.D., BCPP
Senior Pharmacist, Substance Use Disorder/Pain, UC Davis Health, Sacramento, CA
Learning Objectives
1. Practice person-first non-stigmatizing language in the treatment of chronic pain and Substance Related Disorders (SRDs).
2. Review the treatment of chronic pain with Long Term Opioid Therapy (LTOT) in persons with an SRD.
3. Examine barriers to Medication Assisted Treatment (MAT) for chronic pain and Opioid Use Disorder (OUD).
4. Design a treatment plan for the transition to buprenorphine in persons newly diagnosed with an SRD.
5. Formulate perioperative pain management strategies for persons with OUD on buprenorphine undergoing surgery.
Updates in Infectious Disease—Management of Multidrug Resistant Gram-Negative Infections
November 14, 2023 10:15 AM
Activity No. 0217-0000-23-121-L01-P; 1.50 contact hours.
Application Based Activity
- Speaker: Akshith Dass, Pharm.D., BCIDP, BCPS
Infectious Diseases Clinical Coordinator, Cleveland Clinic Mercy Hospital & Assistant Professor in Pharmacy Practice, Northeast Ohio Medical University (NEOMED) College of Pharmacy, Cleveland, OH
Learning Objectives
1. Identify clinically significant gram-negative organisms and infection types.
2. Describe resistance mechanisms of multi-drug resistant (MDR) gram-negative bacteria including extended spectrum beta-lactamases (ESBLs), AmpC beta-lactamase, carbapenem resistance, and difficult-to-treat resistance mechanisms.
3. Evaluate guidelines for the treatment of MDR gram-negative infections.
4. Compare novel beta-lactams and beta-lactam inhibitor combination antibiotics used in the treatment of MDR gram-negative infections.
5. Design appropriate therapeutic regimens for treatment of MDR gram-negative infections.
From Penguins to Pharmacists – Applying Kotter’s Change Model to Lead Transformation
November 14, 2023 10:15 AM
Activity No. 0217-0000-23-150-L04-P; 2.00 contact hours.
Application Based Activity
- Speaker: Todd D. Sorensen, Pharm.D., FCCP
Professor and Senior Executive Associate Dean, University of Minnesota;
Executive Director, Alliance for Integrated Medication Management,
Minneapolis, Minnesota
Learning Objectives
1. Describe the key concepts and stages of Kotter’s leadership model for leading change in organizations.
2. Analyze real-world examples of successful change initiatives using Kotter's model.
3. Apply the organizational change model to a personal leadership opportunity.
Understanding and Addressing Knowledge Gaps with Our Patients
November 14, 2023 10:15 AM
Activity No. 0217-0000-23-118-L04-P; 1.50 contact hours.
Application Based Activity
- Moderator: Eliza A. Dy-Boarman, Pharm.D., BCPS
Learning Objectives
1. Discuss reasons why patients seek out certain sources (e.g., social media) for medical information.
2. Identify common areas and/or topics that may be prone to knowledge gaps amongst patients.
3. Distinguish unsubstantiated medical beliefs from sound evidence-based information.
4. Employ effective communication techniques to address unsubstantiated medical beliefs respectfully and effectively with patients from various cultural backgrounds.
5. Create a plan to build trust with patients to address knowledge gaps.
Understanding Knowledge Gaps Amongst Our Patients
- Speaker: Kendall Guthrie, Pharm.D., BCACP
Applying Tools to Address Unsubstantiated Medical Beliefs
- Speaker: Brandi L. Bowers, Pharm.D., BCACP
Stewardship, Not Just for Infectious Diseases! Designing and Implementing a Stewardship Program for Any Practice Area
November 14, 2023 10:15 AM
Activity No. 0217-0000-23-116-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: William E. Dager, Pharm.D., FCCP, BCPS
Pharmacist Specialist, Department of Pharmaceutical Services,
University of California Davis Medical Center,
Sacramento, California
Learning Objectives
1. Formulate a plan for how to implement a stewardship program.
2. Make recommendations for improving an existing stewardship program.
3. Evaluate how an existing population-based stewardship program can be structured to allow for individualized management plans.
4. Illustrate how integration of stewardship programs within interdisciplinary care teams contributes to interprofessional collaboration and optimization of care.
From Theory to Bedside: The Nuts and Bolts of Building a Stewardship Program
- Speaker: Anthony Hawkins, Pharm.D., BCCCP
Stop the Clot, Stop the Bleed: Implement a Stewardship for AC
- Speaker: Anne Rose, Pharm.D.
Rx for Success: Optimizing OPIOID Safety and Efficacy by Implementing a Stewardship Program
- Speaker: Suzanne A. Nesbit, Pharm.D., FCCP
Clinical Pharmacy Specialist, Pain and Palliative Care, The Johns Hopkins Hospital, Baltimore, Maryland
Panel Discussion
“But I Need Help Now!” Access to Mental Health Services and the Role of Pharmacists
November 14, 2023 10:15 AM
Activity No. 0217-0000-23-108-L04-P; 1.50 contact hours.
Application Based Activity
- Moderator: Louisa Sullivan, Pharm.D., BCEMP, BCPS
Learning Objectives
1. Practice utilizing screening tools to identify mental health conditions.
2. Employ screening tools in various practice settings.
3. Design a plan to identify mental health resources within your community.
4. Investigate the process for referring patients to mental health resources in your community.
5. Create a plan to assess and refer patients for mental health concerns in a variety of practice settings.
How Pharmacists Can Use Screening Tools for Mental Health Conditions
- Speaker: Alisyn L. May, Pharm.D., BCACP, BC-ADM, CDE
Connecting Patients to Mental Health Resources in Any Practice Setting
- Speaker: Lisa Sharp, Ph.D., Master of Arts, Clinical Psychologist
Optimize for Size: Dosing in Obesity
November 14, 2023 10:15 AM
Activity No. 0217-0000-23-114-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: Megan Kunka Fritz, Pharm.D., BCPS
Learning Objectives
1. Recall pharmacokinetic/pharmacodynamic changes in obesity to anticoagulant agents and their interplay.
2. Examine primary literature as it relates to prophylactic and therapeutic anticoagulation dosing strategies in obesity.
3. Assess the application of primary literature on case study examples for patients of various obesity classes and indications for anticoagulation (prophylactic vs. therapeutic).
4. Propose upcoming research initiatives and future directions for the literature on anticoagulants and antimicrobials in obesity.
5. Recall pharmacokinetic/pharmacodynamic changes in antimicrobials in obesity.
6. Assess the application of primary literature on case study examples for patients of various obesity classes and appropriate use of antimicrobials.
Anticoagulation Management in Obesity
- Speaker: George A. Davis, Pharm.D., BCPS
Anticoagulation Program Coordinator, University of Kentucky UK HealthCare, Lexington, Kentucky
Antimicrobial Dosing in Obesity
- Speaker: Nathan A. Pinner, Pharm.D., BCPS
Adult Medicine PRN Focus Session — Building Immunity: A Guide to Managing Immune-Mediated Medications for the General Practitioner
November 14, 2023 1:15 PM
Activity No. 0217-0000-23-124-L01-P; 1.50 contact hours.
Application Based Activity
- Moderator: Haley N. Johnson, Pharm.D., BCPS
Learning Objectives
1. Discuss optimal practices while initiating biologic agents.
2. Recommend appropriate monitoring parameters for biologic agents given a patient case.
3. Distinguish whether various biologic agents should be administered during acute infections or around surgical procedures.
4. Compare dosing recommendations for intravenous immunoglobulin based on indication.
5. Identify monitoring parameters for efficacy and safety of intravenous immunoglobulin therapy.
Initiating and Monitoring Biologic Agents
- Speaker: Sheila M. Wilhelm, Pharm.D., FCCP, BCPS
Clinical Professor and Coordinator of the Patient Care Laboratory
Wayne State University
Detroit, MI
Management of Biologic Agents in Perioperative Settings and Acute Infection
- Speaker: David E. Nix, Pharm.D., FCCP, BCIDP, BCPS
Administering and Monitoring Intravenous Immunoglobulin
- Speaker: Nikitha R. Patel, Pharm.D., BCPS
Community-Based PRN Focus Session — Redefining ‘Accessible’: Community-Based Pharmacists as Frontline Public Health Champions
November 14, 2023 1:15 PM
Activity No. 0217-0000-23-129-L04-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Emily Eddy, Pharm.D., BCACP
Assistant Professor
Director of Labs and Simulations
Texas Tech Jerry H. Hodge School of Pharmacy
Learning Objectives
1. Summarize hormonal contraception recommended guidelines for use.
2. Describe considerations for implementing hormonal contraception services at community-based pharmacies.
3. Summarize HIV PrEP and PEP recommended guidelines for use.
4. Describe considerations for implementing HIV PrEP and PEP services at community-based pharmacies.
5. Summarize long-acting injectable antipsychotic recommended guidelines for use.
6. Describe considerations for implementing behavioral health services at community-based pharmacies.
7. Summarize how offering these services in a community setting has an impact on patient health disparities.
Increasing Access to Hormonal Contraceptive Products: A Community-Based Pharmacist’s Perspective
- Speaker: Lorinda Anderson, Pharm.D., BCPS
Demystifying HIV PrEP and PEP: A Community-Based Pharmacist’s Perspective
- Speaker: Amy Lenell, Pharm.D.
The Expanding Role in Behavioral Health: A Community-Based Pharmacist’s Perspective
- Speaker: Michelle Jeon, Pharm.D., BCACP, AAHIVP
Global Health PRN Focus Session — The Pharmacist’s Role in Care for Refugees and Migrants: Ensuring Equity in Access for All
November 14, 2023 1:15 PM
Activity No. 0217-0000-23-137-L99-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Veena Venugopalan, Pharm.D., BCIDP
Learning Objectives
1. Summarize the differences between the terms refugee, asylum seeker, and migrant.
2. Review explanatory frameworks for understanding the root causes of health inequities for refugees and migrants.
3. Identify contextual and structural factors that influence health status among refugees, and migrants.
4. Describe pharmacist-supported interventions that engage and address health inequities for refugees and migrants.
5. Discuss outcomes of pharmacist-supported interventions developed to meet the needs of refugees and migrants.
6. Discuss the role of the pharmacist in supporting humanitarian missions for refugees and migrants.
Opportunities and Challenges in Achieving Health Equity for Refugees and Migrants Across the Globe
- Speaker: Martha Ndung'u, Pharm.D.
Assistant Professor of Global Health and Health Equity
University of Pittsburgh Global Health PGY2
Pittsburgh, PA
Developing Pharmacy Supported Services for Refugees and Asylum Seekers With Humanitarian Agencies
Engaging Refugee and Migrant Communities to Address Health Equity
- Speaker: Van T. Hellerslia, Pharm.D., BCPS
Health Equity PRN and Health Outcomes PRN Focus Session — Tying the Knot: Marrying Practice With Research Across the Health Equity Continuum
November 14, 2023 1:15 PM
Activity No. 0217-0000-23-138-L99-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Michael R. Gionfriddo, Pharm.D., Ph.D.
Assistant Professor, Geisinger's Center for Pharmacy Innovation and Outcomes, Forty Fort, Pennsylvania
Learning Objectives
1. Describe the value of practice-based research.
2. Discuss how equity-driven research can be incorporated in practice.
3. Describe how practitioners across different practice settings can implement health-equity driven research.
4. Identify key components required to sustain equity-driven practice-based research.
5. Discuss barriers and resources for conducting equity-driven practice-based research.
Pharmacists Conducting Health Equity-Driven Practice-Based Research
- Speaker: Joni C. Carroll, Pharm.D., BCACP
Panel Discussion: Implementing and Sustaining Health Equity-Driven, Practice-Based Research
- Speaker: Sonak Pastakia, Pharm.D., Ph.D., MPH, FCCP
Professor of Pharmacy Practice
Purdue University
Indianapolis, IN
- Speaker: Tyler Marie Kiles, Pharm.D., BC-ADM
- Speaker: Jacqueise M. Unonu, Pharm.D., AAHIVP
Updates in Renal Disease — Evaluation and Management of Chronic Kidney Disease
November 14, 2023 1:15 PM
Activity No. 0217-0000-23-122-L01-P; 1.50 contact hours.
Application Based Activity
- Speaker: Rachel Khan, Pharm.D., BCPS
Learning Objectives
1. Outline the evolution of equations for estimating kidney function.
2. Differentiate methods used to evaluate kidney function.
3. Apply estimation of kidney function equations to medication-related decision-making.
4. Evaluate the use of sodium-glucose cotransporter-2 inhibitors and renin-angiotensin-aldosterone system inhibitors in chronic kidney disease (CKD).
5. Design an evidence-based treatment regimen aimed at slowing the progression of CKD.
Updates in Cardiac Disease — Evaluation and Management of Heart Failure
November 14, 2023 3:00 PM
Activity No. 0217-0000-23-123-L02-P; 1.50 contact hours.
Application Based Activity
- Speaker: Sara D. Brouse, Pharm.D., FCCP, FACC, BCCP, BCPS
Regional Dean & Professor, Clinical Pharmacy Specialist - Cardiology, TTUHSC School of Pharmacy / Hendrick Medical Center, Abilene, TX
- Faculty: Ashley Schenk, Pharm.D., BCCP, BCPS, AACC
Cardiology Clinical Pharmacist / Assistant Adjunct Professor, UK HealthCare / Univ of Kentucky College of Pharmacy, Lexington, KY
Learning Objectives
1. Differentiate between the classifications and four stages of heart failure.
2. Identify medications that may cause or exacerbate heart failure.
3. Evaluate current practice guidelines and consensus recommendations for the treatment of heart failure.
4. Compare medications used in the treatment of heart failure.
5. Develop an evidence-based treatment regimen for a patient with heart failure.
Stress, Life-Balance, Positivity, Well-Being, and Measuring Success in Your Life
November 14, 2023 3:00 PM
Activity No. 0217-0000-23-037-L04-P; 2.00 contact hours.
Application Based Activity
- Speaker: Robert E. Smith, Pharm.D.
Professor Emeritus, Harrison School of Pharmacy, Auburn University, Auburn, Alabama
Learning Objectives
1. Construct a personal plan to improve life-balance and to decrease stress in his/her life.
2.Describe the concept of life-balance and how it might differ from Work-Life Balance.
3. List and describe the five areas of “well-being” and assess how they relate to your life.
4. Describe how leading and managing your life may decrease stress and improve life-balance.
5.List five practices to improve the positivity in your life. Based on your personal mission statement, describe how you will measure success in your life.
When You Don’t Want to Feel the Burn: Tools to Mitigate Burnout in Pharmacy Practice
November 14, 2023 3:00 PM
Activity No. 0217-0000-23-119-L04-P; 1.50 contact hours.
Application Based Activity
- Moderator: Kathleen K. Adams, Pharm.D., BCPS
Learning Objectives
1. Differentiate the impact of individual changes versus organizational changes on employee and organizational engagement.
2. Illustrate ways in which organizations may promote engagement and decrease burnout.
3. Formulate an action plan to improve engagement and decrease burnout in individuals’ work setting.
4. Describe role modifications for a pharmacy practice scenario that could potentially reduce burnout.
5. Describe strategies to advocate for change in organizational culture that supports well-being.
Organizational Change to Beat Burnout in Pharmacy Practice
- Speaker: Brent N. Reed, Pharm.D., MS, FCCP, BCCP, BCPS
Mitigating Burnout in Pharmacy Practice: A Workshop for the Individual Pharmacist
- Speaker: Matt Bilhimer, Pharm.D., BCPS
HIV PRN Focus Session — INSTI It Interesting? An In-Depth Analysis of the First Line ARV Class
November 14, 2023 3:00 PM
Activity No. 0217-0000-23-140-L02-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Daniel B. Chastain, Pharm.D., BCIDP
Learning Objectives
1. Describe the benefits of integrase strand transfer inhibitors compared to protease inhibitors or nonnucleoside reverse transcriptase inhibitors for treatment of HIV.
2. Identify scenarios where the potential toxicities associated with integrase strand transfer inhibitors outweigh the benefits for treatment of HIV.
3. Summarize literature supporting the use of 2-drug integrase strand transfer inhibitor-based antiretroviral therapy for treatment of HIV.
4. Discuss the potential limitations of 2-drug integrase strand transfer inhibitor-based antiretroviral therapy in select populations for treatment of HIV.
5. Identify barriers to implementing integrase strand transfer inhibitors for prevention and treatment of HIV.
6. Describe pharmacists’ role in individualizing and implementing INSTIs for prevention and treatment of HIV.
Balancing the Benefits and Risks Associated With INSTI-Based Regimens
- Speaker: Alex R. Mills, Pharm.D., BCACP, AAHIVP
Expanding the Use of 2-Drug INSTI-Based Regimens for Select Populations
- Speaker: Humberto R. Jimenez, Pharm.D., MPH, AAHIVP
Pharmacists Role in Ending the HIV Epidemic with INSTIs for Prevention and Treatment of HIV
- Speaker: Sarah E. Perez, Pharm.D., BCACP, AAHIVP
Clinical Administration PRN Focus Session — The Pharmacy Technician Pipeline: Recruitment, Retention, and Advancement
November 14, 2023 3:00 PM
Activity No. 0217-0000-23-128-L04-P; 1.50 contact hours.
Application Based Activity
- Moderator: Adriane N. Irwin, Pharm.D., MS, FCCP, BCACP
Associate Professor (Clinical), Oregon State University (OSU) College of Pharmacy and Chair, Department of Pharmacy Practice
Learning Objectives
1. Describe the evolving and expanding role for pharmacy technicians in the healthcare system.
2. List challenges currently impacting recruitment and retention of pharmacy technicians.
3. Design a strategy for recruiting pharmacy technicians.
4. Develop an approach for retaining pharmacy technicians.
5. Discuss innovative roles for pharmacy technicians in community, ambulatory care, and/or inpatient environments.
6. Examine how expanded roles for pharmacy technicians can contribute to an institution’s clinical enterprise.
Filling the Gap: Technician Shortages and Recruitment
- Speaker: Tyler A. Vest, Pharm.D., M.S., FNCAP, BCPS, BCSCP
Maintaining the Workforce: Technician Retention
- Speaker: Cynthia A. Brasher, Pharm.D., MS, BCSCP
Innovative Pharmacy Technician Service Models
- Speaker: William M. Hammonds, Pharm.D., MS, BCPS
- Speaker: Ashley F. Street, Pharm.D., MSHA
- Speaker: Daniel P. O'Neil, Pharm.D., MS
Transplant PRN Focus Session — Deprescribing in Solid Organ Transplantation: When Less Is More
November 14, 2023 3:00 PM
Activity No. 0217-0000-23-141-L01-P; 1.50 contact hours.
Knowledge Based Activity
- Moderator: Jamie Benken, Pharm.D., BCPS
Learning Objectives
1. Explain the risk for polypharmacy and the opportunities for deprescribing in solid organ transplant recipients with chronic kidney disease.
2. Discuss optimization of medication regimens in solid organ transplant recipients to prevent chronic kidney disease progression.
3. Review the negative outcomes in transplant recipients as it relates to perioperative opioid use and describe approaches for successful opioid minimization strategies.
4. Outline specific pharmacologic considerations and how to address polypharmacy in geriatric transplant recipients.
5. Identify approaches to managing medication regimens related to comorbidities in geriatric transplant recipients.
Deprescribing in Solid Organ Transplant Recipients with Chronic Kidney Disease
- Speaker: Amanda J. Condon Martinez, Pharm.D., BCPS, BCTXP
Pharmacological Strategies and Updates for Opioid Minimization Post-Transplant
- Speaker: Alicia Beth Lichvar, Pharm.D., BCPS
Treatment of Comorbidities and Medication Adjustment in Geriatric SOT Recipients
- Speaker: Nicole R. Alvey, Pharm.D., FAST, BCPS, BCTXP